Carevive SMART Data – EVALUATE

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly, the invaluable trends that longitudinal real-world data sets can reveal about the patient experience. Lastly, how digital tools empower clinicians to predict and manage the experiences of cancer patients more effectively.

With a comprehensive approach, Carevive is transforming cancer care by harnessing the power of patient experience insights. Join us on this transformative journey as we continue to make a positive impact on the lives of cancer patients and their healthcare providers. Together, we build a brighter future for cancer care, one step at a time.

Recent Episodes

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Healthcare generates enormous volumes of clinical data, yet making sense of that information in real time remains a challenge. Subtle changes in vitals, labs, and nursing assessments often precede serious events, but when that information is fragmented across the medical record, emerging risks can go unnoticed. The central challenge facing hospitals today is not…

As the Patient Monitoring series concludes, the conversation shifts from today’s challenges to tomorrow’s possibilities. This final episode of the five-part Health and Life Sciences at the Edge series looks ahead to what healthcare could become if patient monitoring gets it right. Intel’s Kaeli Tully is joined by Sudha Yellapantula, Senior Researcher at Medical…